Stem cell treatment for fractures is safe in small study

07/9/2013 | Healio

A fluoroscopic-delivered composite graft that combines autologous mesenchymal stem cells, platelet-rich plasma and demineralized bone matrix proved safe as a treatment for distal tibial fracture, based on a small randomized study in Israel. "Future applications of freshly isolated MSCs may include delivery with active signal molecules and transient or permanent genetic and functional modifications of the cells. This graft, in turn, may be applied preventively in cases where difficulties in fracture healing are foreseen," the study authors wrote.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN